ClinicalTrials.gg
Drug

Piperaquine clinical trials

studies test it
94
open now
7
in phase 3
36
first study started
2003

How each study uses piperaquine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the piperaquine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
27 Oct 2011 · Eurartesim · EMEA/H/C/001199 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Piperaquine
5
piperaquine phosphate
3
Piperaquine (high dose)
2

In one entry with another drug

Given together, or one or the other

Dihydroartemisinin-piperaquine
40
Eurartesim
21
Dihydroartemisinin-piperaquine (DP)
10
Dihydroartemisinin piperaquine
9
Artekin
9
Duo-Cotecxin
8
D-Artepp
7
DuoCotecxin
4

Studies by the year they started

94 studies that test it; most in 2010 (9)

Studies that test piperaquine, by start year
YearStudies
20031
20074
20082
20091
20109
20113
20127
20138
20147
20157
20164
20173
20185
20194
20204
20215
20228
20232
20243
20252
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
11
Phase 2
7
Phase 3
36
Phase 4
30
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 89

University of Oxford (9) · University of California, San Francisco (7) · London School of Hygiene and Tropical Medicine (7) · Liverpool School of Tropical Medicine (6) · Medicines for Malaria Venture (5) · National Institute for Medical Research, Tanzania (4) · Radboud University Medical Center (3) · sigma-tau i.f.r. S.p.A. (3)

Often tested with

Tested in the same studies.

Artenimol (83) · Fanasil, pyrimethamine drug combination (14) · Artemether, Lumefantrine Drug Combination (11) · Amodiaquine (9) · Chloroquine (6) · Artesunate (5) · Primaquine (4) · Artefenomel (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test piperaquine, phase 3 first.

Studies

Open first, then newest update. How each study uses piperaquine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 94

See all 94 studies that test piperaquine →

Given beside what is tested · 11 — piperaquine is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with piperaquine

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call piperaquine · ClinicalTrials.gg INT003036

  • MeSH (NLM) C034759piperaquineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) A0HV2Q956YPIPERAQUINEConfirmed FDA, NLM, Wikidata
  • Wikidata Q7197338piperaquineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87634PiperaquineOne source FDA
  • DrugBank DB13941One source Wikidata

Also registered as piperaquine monophosphate (UNII 5A17BAT3GK), piperaquine phosphate (UNII IHB5WLO51Q) and piperaquine phosphate tetrahydrate (UNII 854D7K8LXB).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.